Skip to main content
Premium Trial:

Request an Annual Quote

Progenra Licenses Dotmatics' Informatics Suite for Drug Discovery

Premium

Dotmatics said recently that Progenra, a Malvern, Penn.-based biotechnology company, has licensed its informatics platform to support drug discovery and development efforts around the ubiquitin-proteasomal pathway of cellular protein regulation

Marc Hixson, Progrenra's senior director for business development, said in a statement that the company chose to replace its existing informatics suite — which was provided by CambridgeSoft — with Dotmatics' platform "because of the seamless interface and ease of use which has allowed Progenra to effectively and efficiently manage their internal and external programs."

This current license provides Progenra with access to Dotmatics' tools like Browser which is an interactive query, reporting and dashboard; Studies, which captures biological assay data; and Vortex, which provides an environment for predictive analytics, visualization, and analysis of data.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.